Concepedia

Bryan Selby

BS

Statistics

Publications

4

Citations

5.1K

H-Index

4

Active since

2012

Affiliations

Université de Montréal(Current)

Carolina Urologic Research Center

Institut Gustave Roussy

Duke University

Chesapeake Urology Associates

Bryan Selby is an author at Université de Montréal specializing in prostate cancer hormonal therapy, medicine, and prostate cancer.

Publications per year

2012–2023

4

Publications

4

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

Howard I. Scher, Karim Fizazi, Fred Saad et al. · New England Journal of Medicine · 2012 · 4.6K citations · Full text

, , +14

Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer

Neal D. Shore, Fred Saad, Michael S. Cookson et al. · New England Journal of Medicine · 2020 · 436 citations · Full text

, , +17

Effect of MDV3100, an androgen receptor signaling inhibitor (ARSI), on overall survival in patients with prostate cancer postdocetaxel: Results from the phase III AFFIRM study.

Howard I. Scher, Karim Fizazi, Fred Saad et al. · Journal of Clinical Oncology · 2012 · 117 citations

, , +13

Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate Cancer

Daniel J. George, Fred Saad, Michael S. Cookson et al. · Clinical Genitourinary Cancer · 2023 · 14 citations · Full text

, , +10

1–4 of 4